company mission on targeting aging to extend healthy lifespan
Not much evolved here. The September 2022 and February 2023 statements say essentially the same thing: Zoe Biosciences claims it is "redefining healthy lifespan" by building therapeutics for age-related diseases and aging itself. The core belief stayed fixed: aging is not just background scenery, but something you can target directly. What changed is mostly phrasing at the margins. One version says targeting aging can "help create" longer, disease-free lives; the later one says it should be targeted "in order to enable" them. That is not a strategic turn. It is copy editing wearing a lab coat. Evidence is thin because we only have two website snapshots, five months apart, with near-identical language. So the fair reading is stability, not evolution. If there was any internal shift in mission, ambition, or confidence, it did not show up here.